Related by context. All words. (Click for frequent words.) 75 mucinous 72 invasive ductal 71 lobular carcinoma 71 gastric cardia 69 adenocarcinomas 69 hamartomas 69 atypical hyperplasia 69 gastric adenocarcinoma 69 sarcomatoid 69 serous ovarian cancer 69 skeletal metastases 69 leiomyomas 69 leiomyoma 68 seminomas 68 metastatic prostate 68 epithelial tumors 68 invasive carcinoma 68 histologic subtype 68 ductal carcinomas 67 urothelial carcinoma 67 ductal breast cancer 67 prostate carcinoma 67 breast endometrial 67 paragangliomas 67 ductal 67 advanced adenomas 67 liver metastasis 67 malignant prostate 67 nodal metastasis 67 HER2 overexpression 67 invasive lobular 67 renal cell carcinomas 67 progesterone receptor negative 67 colorectal adenocarcinoma 67 metastatic lymph nodes 67 hydronephrosis 67 node metastases 67 tumoral 67 ductal lobular 66 locoregional recurrence 66 cisplatin resistant 66 carcinomatosis 66 GISTs 66 papillary 66 lymph node metastasis 66 invasive carcinomas 66 gastric carcinoma 66 pancreatic adenocarcinoma 66 malignant nodules 66 choriocarcinoma 66 cervical lymph nodes 66 Papillary 66 Squamous 66 neoplasias 66 cellularity 66 CIN2 + 66 endometrioid 66 breast carcinoma 66 squamous cell carcinoma SCC 66 histological subtype 66 epithelioid 66 neoplasms 66 SLNB 65 situ LCIS 65 calculi 65 endometrial carcinoma 65 intestinal metaplasia 65 lung carcinomas 65 pancreatic lung 65 osteoid 65 mutated K ras 65 colorectal gastric 65 ductal cancer 65 progesterone receptor PR 65 adenomatous polyps 65 precursor lesions 65 osteosarcomas 65 HGPIN 65 lobular 65 bladder cancers 65 colorectal pancreatic 65 ovarian carcinoma 65 HER2 expression 65 atypical ductal hyperplasia 65 malignant neoplasm 65 metaplasia 65 mesotheliomas 65 hyperplastic 65 thyroid nodules 65 colorectal carcinoma 65 pleural fluid 65 intracranial hemorrhage ICH 65 polypoid 65 peritoneal fluid 65 breast carcinomas 65 sonographically 65 pituitary adenomas 65 pT3 64 prostate adenocarcinoma 64 endometrial hyperplasia 64 rebleeding 64 colorectal polyp 64 adrenocortical cancer 64 renal tumors 64 CIN3 64 Candida infection 64 intraductal 64 Sezary syndrome 64 lymphadenopathy 64 distant metastasis 64 eccrine 64 thyroid carcinoma 64 histologic subtypes 64 LV dysfunction 64 lymphovascular invasion 64 invasive lobular carcinoma 64 sonographic findings 64 BRCA1 mutation carriers 64 SUVmax 64 carcinoid 64 lobular cancer 64 malignant growths 64 urothelial cancer 64 SSc 64 schwannomas 64 neoplastic 64 needle aspiration 64 prostate cancer CaP 64 extrahepatic 64 hematopoietic cancers 64 colorectal neoplasms 64 epididymal 64 HER2 positive cancers 64 polypoid lesions 64 pancreatic endocrine 64 basal cell carcinoma BCC 64 nonischemic 64 antiproliferative effects 64 lung pancreatic 64 peritoneal carcinomatosis 64 endometrial cancers 64 renal pelvis 64 pleural effusions 64 hypoperfusion 64 chromosomal mutations 63 prostate bladder 63 distal colon 63 lymphadenectomy 63 proliferative disorders 63 prostate carcinomas 63 catheter angiography 63 HbF 63 Hurthle cell 63 micrometastasis 63 hormone receptor negative 63 arterial calcification 63 oesophageal adenocarcinoma 63 supratentorial 63 colonic polyps 63 mesenteric 63 myeloproliferative diseases 63 micrometastases 63 orthotopic 63 Mitomycin C 63 nonmelanoma skin cancers 63 tumor histology 63 T1a 63 lymph node involvement 63 Heavy menstrual bleeding 63 K ras mutations 63 testicular cancers 63 cervical intraepithelial neoplasia 63 papillary renal cell carcinoma 63 lymphocytosis 63 HER2 neu 63 carotid plaques 63 deCODE BreastCancer 63 thyrotoxicosis 63 nonmetastatic 63 neuroendocrine cancers 63 papillary carcinoma 63 nodal metastases 63 obstructive coronary artery 63 salpingo oophorectomy 63 malignant lesions 63 lymph node enlargement 63 chemosensitivity 63 histologies 63 lobular involution 63 thrombi 63 ovarian lung 63 molecular abnormalities 63 benign noncancerous 63 hepatocellular carcinomas 63 hamartoma 63 distant metastases 63 papillary thyroid carcinoma 63 retroperitoneal 63 intestinal polyps 63 Endometrial 63 situ CIS 63 neurofibromas 63 hepatoma 63 pulmonary metastasis 63 haematopoietic 63 Leukemias 63 cytoreductive surgery 63 PCa 63 lobular breast cancer 63 uterine cervix 63 metastatic neuroendocrine tumors 63 neoadjuvant therapy 63 colorectum 63 pancreatic prostate 63 neoplasm 63 mycosis fungoides 63 Metastases 63 ASCUS 63 extracapsular extension 63 immunohistochemical analysis 63 Radiofrequency ablation 63 neoplasia 63 colorectal adenoma 63 advanced adenoma 63 sonographic appearance 62 osteolytic 62 recurrent ovarian 62 splenic 62 cystic lesions 62 invasive ductal carcinoma 62 renal cysts 62 contralateral breast 62 postoperative morbidity 62 lymph node metastases 62 nephrogenic 62 xenograft tumors 62 Carcinoid tumors 62 adnexal mass 62 carotid stenosis 62 infarcts 62 osteoblastic 62 Gliomas 62 p# mutation 62 radiographic findings 62 metastatic malignant melanoma 62 chlamydial infection 62 epithelial ovarian 62 hematologic toxicity 62 thyroglobulin 62 TT genotype 62 endobronchial 62 brain parenchyma 62 cytoreduction 62 neoplastic lesions 62 sonographically guided 62 specific antigen PSA 62 transfusion syndrome 62 carcinoembryonic antigen 62 ovarian breast 62 malignant ovarian 62 malignant neoplasms 62 echogenicity 62 malignant lymphomas 62 Basal cell 62 metachronous 62 pulmonary metastases 62 breast uterine 62 intraoperative complications 62 castrate resistant 62 urothelial 62 esophageal gastric 62 prostatic tissue 62 pT2 62 testicular tumors 62 metastatic lesions 62 intracranial tumors 62 hypervascular 62 gastric cancers 62 transgene expression 62 uterine ovarian 62 lung nodules 62 fibroma 62 proximal colon 62 anaplastic 62 T1c 62 isoenzyme 62 nonvascular 62 premalignant lesions 62 Immunohistochemical staining 62 chromophobe 62 thyroid carcinomas 62 HER2 positive breast 62 transabdominal 62 MALT lymphoma 62 tumor nodules 62 endocervical 62 ERBB2 62 cTnI 62 neutrophil counts 62 elevated LDH 62 extracranial 62 neoplastic cells 62 adenomatous 62 proton MR spectroscopy 62 coronary stenosis 62 wedge resection 62 atherothrombotic 62 urethritis 62 cTnT 62 hilar 62 HER2 negative 62 germline mutation 62 PSA nadir 62 papillomas 62 trophoblastic 62 lipomas 62 lymphocytic 62 ABCB1 62 HER2 positive tumors 62 radiochemotherapy 62 EUS FNA 61 intact parathyroid hormone 61 mammary cancers 61 renal carcinoma 61 thrombotic complications 61 paraganglioma 61 meningiomas 61 HER2 receptor 61 invasive ductal carcinomas 61 lymphomas leukemias 61 Basal Cell 61 trophoblasts 61 cyclin E 61 benign nodules 61 varices 61 oncologic outcomes 61 lactate dehydrogenase 61 uterine tumors 61 chromosomal rearrangement 61 pleurodesis 61 urine cytology 61 extramedullary 61 VEGF expression 61 thymectomy 61 LVNC 61 Endometrial cancer 61 angiographically 61 thromboembolic disease 61 mammographically 61 HER2 amplification 61 neointimal hyperplasia 61 coagulation abnormalities 61 cervical carcinoma 61 hemorrhagic cystitis 61 endometrial 61 operable breast cancer 61 pancreatic ovarian 61 sclerosing 61 carcinoids 61 lung ovary 61 fulminant hepatic failure 61 cholangiocarcinoma 61 metastatic gastric 61 squamous carcinoma 61 pleomorphic 61 immunoreactivity 61 node dissection 61 incidentalomas 61 bronchogenic carcinoma 61 pheochromocytoma 61 fibrocystic 61 percutaneous biopsy 61 bronchial epithelial cells 61 haematologic 61 neuroblastomas 61 pheochromocytomas 61 cholelithiasis 61 etiologic 61 seminal vesicle 61 malignant polyps 61 fluconazole resistant 61 carotid plaque 61 FDG uptake 61 fibroadenomas 61 completely resected 61 LRP5 61 carcinoid tumor 61 hemorrhagic complications 61 pelvic lymphadenectomy 61 ovarian malignancy 61 urolithiasis 61 myoma 61 gastroesophageal junction 61 peritoneal cancer 61 cytological 61 heparanase 61 CD# expression [001] 61 ovarian endometrial 61 grade cervical intraepithelial 61 colorectal liver metastases 61 lung adenocarcinomas 61 adjuvant radiotherapy 61 metastatic melanomas 61 surgically resectable 61 breast pancreatic 61 localized renal 61 para aortic 61 endometrial ovarian 61 colorectal carcinomas 61 ERalpha 61 EGFR mutant 61 bone scintigraphy 61 hypermethylated 61 ischemic lesions 61 ovarian pancreatic 61 mediastinitis 61 Fas ligand 61 anemia thrombocytopenia 61 proctitis 61 breast abscesses 61 chemoembolization 61 gastrointestinal stromal tumors GISTs 61 hepatocellular 61 ano genital warts 61 lobule 61 Fibroid tumors 61 cancerdefine 61 TMPRSS2 ERG 61 ductal adenocarcinoma 61 scintigraphic 61 atrophic gastritis 61 NSCLC tumors 61 pulmonary angiography 61 sCJD 61 synovial cells 61 vaginal lesions 61 PrPSc 61 Squamous cell 61 calcified plaques 61 squamous 61 thyrotropin 61 lupus anticoagulant 61 astrocytomas 61 ADPKD 61 bronchoalveolar lavage 61 pCR 61 histologically 61 TEAEs 61 sentinel lymph node biopsy 61 mammographic density 61 periodontal bacteria 61 myometrium 61 Metastatic 61 Histologically 61 LHRH receptor positive 61 myopathies 61 melanoma lesions 61 synovial 61 KRAS mutations 61 aerodigestive tract 61 Colon polyps 61 intraepithelial 61 biliary tree 61 radiosensitivity 61 nucleated cells 61 unresectable tumors 61 NMIBC 61 untreated celiac disease 61 adrenalectomy 61 submucosa 61 bladder prostate 61 LV ejection fraction 61 renal parenchyma 60 lymphoid tissue 60 prostate colon 60 neuroendocrine carcinoma 60 esophageal carcinoma 60 neovasculature 60 helical CT 60 CIN2 60 varicoceles 60 differential gene expression 60 Glucocorticoids 60 p# mutations 60 lobules 60 tumor metastases 60 N. gonorrhoeae 60 thromboembolism 60 BCR ABL mutations 60 unconjugated 60 treat menorrhagia 60 granulosa cell 60 radiotherapy RT 60 kidney cysts 60 glial tumors 60 Pelvic Inflammatory Disease 60 nonalcoholic steatohepatitis NASH 60 T2 lesions 60 HBeAg negative 60 aplasia 60 axillary lymph nodes 60 Radical prostatectomy 60 Thal Dex 60 Toxicities 60 fibrin deposition 60 chloride secretion 60 Nanobacteria 60 metastatic malignant 60 EGFR HER2 60 tricuspid regurgitation 60 adenomatous polyp 60 myeloperoxidase 60 follicular thyroid cancer 60 ultrasonographic 60 BMPR2 60 allogeneic HSCT 60 ADAMTS# 60 precancerous cervical 60 deep venous thromboses 60 atherosclerotic lesions 60 squamous intraepithelial lesions 60 bacteriuria 60 leukocytosis 60 postoperative chemotherapy 60 FDG-PET/CT 60 prostate cancer PCa 60 nutlin 3a 60 Cysts 60 homogenates 60 interleukin IL -# 60 pericardial effusion 60 osteochondroma 60 cervical lymph node 60 oligodendroglioma 60 FGFR2 60 lymphoproliferative disorders 60 sequence homology 60 adnexal masses 60 B7 H3 60 apocrine 60 dysplastic lesions caused 60 hepatic cirrhosis 60 ependymomas 60 parenchymal 60 percutaneous drainage 60 myoepithelial 60 tissue microenvironment 60 pathologic examination 60 EGFR tyrosine kinase inhibitors 60 chromosomal aberrations 60 metastatic GIST 60 resectable 60 periventricular 60 ovarian cervical 60 immunohistochemical 60 coagulopathy 60 KIT mutations 60 premalignant 60 cranial irradiation 60 microsatellite instability 60 MGUS 60 Lymph node 60 small lymphocytic lymphoma 60 Helicobacter pylori infection 60 CD#c 60 seroma 60 carcinoid tumors 60 cerebral vasospasm 60 gene BRCA2 60 herpesviruses 60 hormone therapy estrogen 60 perineural invasion 60 PCNSL 60 acute aortic dissection 60 mTOR inhibitors 60 perianal 60 axillary lymph node 60 seminoma 60 anal cancers 60 PARP inhibition 60 tumor xenografts 60 hepatic fibrosis 60 excisional biopsy 60 epididymitis 60 debulking surgery 60 kidney urologic 60 malignant ascites 60 lymphoid 60 baseline LDH 60 Adenomas 60 serum IgE 60 fibrocystic changes 60 elevated CRP 60 bladder ovarian 60 transthyretin amyloidosis 60 mutant p# 60 underwent resection 60 lymphoid tissues 60 lytic 60 TMPRSS2 ERG fusion 60 polyposis 60 squamous cell lung cancer 60 chlamydial 60 Barrett mucosa 60 androgen ablation 60 postoperative complication 60 inherited mutations 60 TIMP 60 neuroblastoma tumors 60 histological diagnosis 60 mesothelial cells 60 immunocompetent 60 Recurrences 60 Ischemic 60 MCF7 60 cellular prion protein 60 estrogen receptor ER 60 Nodules 60 Inhibin B 60 TGF beta1 60 pyrimethamine 60 axillary node 60 F FDG uptake 60 mediastinal lymph nodes 60 immunoreactive 60 teratoma 60 gene rearrangements 60 gonococcal infection 60 atypia 60 hormone receptor status 60 histopathologic findings 60 deCODE BreastCancer TM 60 H. pylori eradication 60 BRCA1 BRCA2 60 interferon γ 60 Epstein Barr Virus EBV 60 immunohistochemical staining 60 submucosal 60 hepatic arterial 60 Legg Calvé Perthes disease 60 choroidal 60 lichen planus 60 mesangial 60 carcinomas 60 gynecological malignancies 60 mononuclear 60 eosinophil count 60 multinucleated 60 esophagogastric junction 60 chemoresistant 60 mtDNA mutations 60 primary hyperparathyroidism 60 mononuclear cells 60 gene amplification 60 fine needle aspiration 60 dysplastic lesions 60 malignant pleural mesothelioma 60 histologically proven 60 coronary vessels 60 nasopharyngeal carcinoma 60 orchitis 60 leukaemias 59 oesophageal 59 KRAS oncogene 59 ALK mutations 59 adrenocortical 59 histopathologic examination 59 noncardiac 59 lung metastasis 59 BRAF V#E 59 epithelia 59 biochemical recurrence 59 adventitia 59 radioiodine therapy 59 adrenal cortex 59 radical nephrectomy 59 CYT# potent vascular disrupting 59 oncogenic mutations 59 ALT elevation 59 micronuclei 59 renal cortical 59 IgA deficiency 59 cutaneous melanoma 59 basal cell cancers 59 immunopathology 59 EBRT 59 hyperalgesia 59 metastatic colorectal 59 thymidylate synthase TS 59 benign neoplasms 59 aneuploidies 59 epithelial cancers 59 CagA 59 myomas 59 endometrial thickness 59 cervicitis 59 Prostatic 59 thromboembolic 59 medically inoperable 59 platelet reactivity 59 natriuretic peptides 59 PNET 59 congenital malformations 59 lymphoid cells 59 molecular subtypes 59 bacterial vaginosis BV 59 oligodendrogliomas 59 histologic examination 59 pulmonary nodules 59 neurologic complications 59 pathogenic mutations 59 Adenocarcinoma 59 T2 weighted images 59 lymph node removal 59 SOD2 gene 59 ccRCC 59 malignant phenotype 59 explants 59 epithelial ovarian cancer 59 tryptase 59 anal lesions 59 extracapsular 59 cytologic 59 osteochondromas 59 prostate ovarian 59 hepatocellular carcinoma liver 59 myeloproliferative 59 necrotizing 59 advanced neoplasia 59 Vidaza ® 59 intravenous bisphosphonates 59 mosaicism 59 Venous thromboembolism 59 PC# cells 59 endometrial cells 59 coronary artery stenosis 59 Chronic pancreatitis 59 BPH benign prostatic 59 coronary blockages 59 osteoid osteoma 59 intracerebral 59 myocardial fibrosis 59 malignant fibrous histiocytoma 59 Circulating tumor cells 59 Uterine cancer 59 multimodality therapy 59 gadolinium enhanced 59 Estrogen receptor positive 59 intraepithelial neoplasia 59 vaginalis 59 cerebral infarction 59 amenorrhoea 59 fallopian tube cancers 59 cytopathic 59 histological subtypes 59 candidemia 59 ZNF# 59 cytokeratin 59 acute GvHD 59 TOP2A 59 granulomatous 59 noncalcified 59 SPINK1 59 etiologies 59 Malignant tumors 59 breast lesions 59 bronchoalveolar 59 postpartum hemorrhage 59 hypercoagulable 59 renal scarring 59 adenomyosis 59 nanomolar 59 endocrine tumors 59 hypervascular tumors 59 Androgen deprivation therapy 59 Metastatic breast cancer 59 bacterial prostatitis 59 mutated KRAS gene 59 microdeletions 59 haematuria 59 cardiac tamponade 59 ventricular myocardium 59 hydatid cyst 59 lung epithelium 59 grade squamous intraepithelial 59 atherothrombotic disease 59 myofibroblasts 59 #Gy 59 clinicopathological features 59 gynecologic malignancy 59 Relapsing remitting MS 59 pathologic diagnosis 59 idiopathic myelofibrosis 59 MYCN amplification 59 fibroids endometriosis 59 preoperative chemotherapy 59 hereditary predisposition 59 pleural mesothelioma 59 somatostatin receptors 59 colorectal tumors 59 intrahepatic 59 dimeric 59 motor neuron degeneration 59 gastrointestinal cancers 59 tonsillar 59 Uterine fibroids 59 neoadjuvant chemotherapy 59 serum prostate 59 cystectomy 59 hepatic metastases 59 Glioblastomas 59 thromboembolic events 59 radiosensitive 59 thyroid nodule 59 tumorigenicity 59 submandibular gland 59 bowel cancers 59 axillary dissection 59 Pneumocystis carinii pneumonia 59 pulmonary resection 59 submandibular 59 spontaneously regress 59 Doppler sonography 59 metastatic lesion 59 somatic mutations 59 mesothelium 59 clinicopathologic 59 fallopian tube carcinoma 59 antitumor effect 59 orchiectomy 59 Ki# 59 ErbB2 positive 59 atypical lobular hyperplasia 59 serum urate levels 59 Neisseria gonorrhoeae 59 alkaline phosphatase ALP 59 activating mutations 59 repigmentation 59 lymph node dissection 59 multicentric 59 immunostaining 59 intravesical therapy 59 System IPSS 59 haematological 59 bioavailable testosterone 59 hypointense 59 HepG2 cells 59 β blockers 59 clonogenic 59 transthoracic 59 clade B 59 metastatic tumors 59 synovial tissue 59 Adjuvant chemotherapy 59 pAkt 59 immunomodulatory properties 59 Trichomonas vaginalis 59 transvaginal sonography 59 Leydig cells 59 pelvic lymph nodes 59 Carcinomas 59 preoperative PSA 59 perioperative complications 59 transarterial 59 relapsed MM 59 myelofibrosis polycythemia vera 59 Actinic Keratosis 59 allograft rejection 59 TGF ß1 59 astrocytic 59 congenital anomalies 59 plasmacytoid 59 estrogen receptor progesterone receptor 59 situ DCIS 59 penile cancers 59 bladder carcinoma 59 glutamyl 59 PDGFR alpha 59 pre malignant lesions 59 Benign tumors 59 lung epithelial cells 59 leucopenia 59 Clusterin 59 RQ PCR 59 nondiabetic patients 59 adenoma 59 prognostic indicator 59 Leydig cell 59 bilateral oophorectomy 59 hyperhomocysteinemia 58 seminal vesicles 58 cardiac dysfunction 58 Western blotting 58 TGF beta signaling 58 curative resection 58 lung nodule 58 transitional cell carcinoma 58 cytotoxic therapies 58 prostate pancreatic 58 malperfusion 58 Glioblastoma multiforme GBM 58 rectal cancers 58 acinar 58 TEL AML1 58 hyperoxaluria 58 cytotoxic effects 58 Brain metastases 58 Brugada syndrome 58 hypoxemia 58 tumor necrosis 58 core needle biopsies 58 GnRH agonists 58 parenchyma 58 fetal malformations 58 pelvic malignancies 58 mitochondrial toxicity 58 GIST tumors 58 microvessel density 58 pituitary adenoma 58 radical prostatectomy RP 58 biochemical abnormalities 58 vimentin 58 hormone receptor positive 58 BRCA deficient 58 urethral strictures 58 postoperative mortality 58 resections 58 PI3K AKT 58 chronic periodontitis 58 serum homocysteine 58 precancerous condition 58 TIMP 1 58 globular proteins 58 leukemias lymphomas 58 infiltrative 58 solar keratosis 58 IgG4 58 APOL1 58 axilla 58 biliary obstruction 58 prostate abnormalities 58 flutamide 58 macrovascular events 58 mutated KRAS 58 intratumoral 58 proteoglycan 58 myelomas 58 methicillin susceptible Staphylococcus aureus 58 E. faecalis 58 papillomatosis 58 hepatorenal syndrome 58 multivessel disease 58 inducible nitric oxide synthase 58 hyperplastic polyps 58 malignant cancerous 58 pyelonephritis 58 cardiogenic 58 genital ulcers 58 tumors GIST 58 androgen receptor AR 58 geographic atrophy 58 mediastinum 58 LHRH analogues 58 basal cell nevus syndrome 58 thrombo embolic 58 tunica vaginalis 58 GBMs 58 ovarian tumors 58 androgen dependent 58 p# activation 58 Aspergillus species 58 anal canal 58 glomerular 58 gastroduodenal 58 prostatic 58 prostate TURP 58 recurrent venous thromboembolism 58 genital herpes infections 58 neointimal 58 perivascular 58 TTR gene 58 NNRTI resistance 58 estrogen receptor negative 58 relapsed ovarian cancer 58 sFlt 1 58 parathyroid 58 trans retinoic acid 58 resected tumors 58 CIN3 + 58 sitosterol 58 mucus glands 58 epithelial tissues 58 pancreatic ductal 58 karyotypes 58 promoter methylation 58 histiocytes 58 neurosensory 58 de ath 58 B Cell Lymphoma